PPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells

Neurotoxicity Research

Volumn 25, Issue 3, 2014, Pages 311-322

  Wojtowicz, Anna K ^a   Szychowski, Konrad A ^a   Kajta, Małgorzata ^b  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Apoptosis; GW1929; Neocortex; Neurotoxicity; PPAR ; TBBPA

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CASPASE 3; LACTATE DEHYDROGENASE; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; FETUS; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; NEOCORTEX; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANILIDES; ANIMALS; APOPTOSIS; BENZOPHENONES; CASPASE 3; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; MICE; NEOCORTEX; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; POLYBROMINATED BIPHENYLS; PPAR GAMMA; TIME FACTORS; TYROSINE;

EID: 84896052759     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9434-z     Document Type: Article

References (53)

1. Akasaki Y, Liu G, Matundan HH, Ng H, Yuan X, Zeng Z, Black KL, Yu JS (2006) A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. J Biol Chem 281:6165-6174 (Pubitemid 43847546)
2. Alaee M, Arias P, Sjödin A, Bergman A (2003) An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release. Environ Int 29:683-689 (Pubitemid 37337114)
3. +-ATPase inhibition, beta-amyloid peptide release and apoptosis in SH-SY5Y neuronal cells. PLoS ONE 7:e33059
4. Birnbaum LS, Staskal DF (2004) Brominated flame retardants: cause for concern? Environ Health Perspect 112:9-17 (Pubitemid 38081507)
5. Bishop-Bailey D, Hla T, Warner TD (2000) Bisphenol A diglycidyl ether (BADGE) is a PPAR-γ agonist in an ECV304 cell line. Br J Pharmacol 131:651-654
6. Brewer GJ (1995) Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42:674-683
7. Chiang MC, Cheng YC, Lin KH, Yen CH (2013) PPAR-γ regulates the mitochondrial dysfunction in human neural stem cells with tumor necrosis factor alpha. Neuroscience 229:118-129
8. Chu K, Lee ST, Koo JS, Jung KH, Kim EH, Sinn DI, Kim JM, Ko SY, Kim SJ, Song EC, Kim M, Roh JK (2006) Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 1093:208-218 (Pubitemid 43946402)
9. Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S (2005) Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acidreceptors (RXRs) in rat cortical neurons. Neuroscience 130:325-337 (Pubitemid 40125471)
10. Covaci A, Voorspoels S, Abdallah MA, Geens T, Harrad S, Law RJ (2009) Analytical and environmental aspects of the flame retardant tetrabromobisphenol- A and its derivatives. J Chromatogr A 1216:346-363
11. Cristiano L, Bernardo A, Cerù MP (2001) Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes. J Neurocytol 30:671-683
12. de Wit CA, Herzke D, Vorkamp K (2010) Brominated flame retardants in the Arctic environment-trends and new candidates. Sci Total Environ 408:2885-2918
13. Garrido-Gil P, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease. J Neuroinflammation 22:9-38
14. Gray E, Ginty M, Kemp K, Scolding N, Wilkins A (2012) The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. J Neuroinflammation 5(9):63
15. Hendriks HS, van Kleef RG, van den Berg M, Westerink RH (2012) Multiple novel modes of action involved in the in vitro neurotoxic effects of tetrabromobisphenol-A. Toxicol Sci 128:235-246
16. Heneka MT, Klockgether T, Feinstein DL (2000) Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 20:6862-6867
17. Johnson-Restrepo B, Adams DH, Kannan K (2008) Tetrabromobisphenol A (TBBPA) and hexabromocyclododecanes (HBCDs) in tissues of humans, dolphins, and sharks from the United States. Chemosphere 70:1935-1944 (Pubitemid 351200473)
18. Kajta M, Lasoń W, Kupiec T (2004) Effects of estrone on N-methyl-D-aspartic acid- and staurosporine-induced changes in caspase-3-like protease activity and lactate dehydrogenase-release: time- and tissue-dependent effects in neuronal primary cultures. Neuroscience 123:515-526 (Pubitemid 38032927)
19. Kajta M, Trotter A, Lasoń W, Beyer C (2005) Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells. Brain Res Dev Brain Res 160:40-52 (Pubitemid 41512805)
20. Kaundal RK, Sharma SS (2011) Ameliorative effects of GW1929, a nonthiazolidinedione PPAR-γ agonist, on inflammation and apoptosis in focal cerebral ischemic-reperfusion injury. Curr Neurovasc Res 8:236-245
21. Kibakaya EC, Stephen K, Whalen MM (2009) Tetrabromobisphenol A has immunosuppressive effects on human natural killer cells. J Immunotoxicol 6:285-292
22. Kiciński M, Viaene MK, Den Hond E, Schoeters G, Covaci A, Dirtu AC, Nelen V, Bruckers L, Croes K, Sioen I, Baeyens W, Van Larebeke N, Nawrot TS (2012) Neurobehavioral function and low-level exposure to brominated flame retardants in adolescents: a cross-sectional study. Environ Health 11:86
23. Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT (2003) Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther 307:505-517 (Pubitemid 37310663)
24. Kim KY, Cho HS, Lee SH, Ahn JH, Cheon HG (2011) Neuroprotective effects of KR-62980, a new PPAR-γ agonist, against chemical ischemia-reperfusion in SK-N-SH cells. Brain Res 1372:103-114
25. Kitamura Y, Shimohama S, Koike H, Kakimura Ji, Matsuoka Y, Nomura Y, Gebicke-Haerter PJ, Taniguchi T (1999) Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 254:582-586 (Pubitemid 29290509)
26. Moreno S, Farioli-Vecchioli S, Cerù MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123:131-145 (Pubitemid 37518482)
27. Nakajima A, Saigusa D, Tetsu N, Yamakuni T, Tomioka Y, Hishinuma T (2009) Neurobehavioral effects of tetrabromobisphenol A, a brominated flame retardant, in mice. Toxicol Lett 189:78-83
28. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
29. Pereira MP, Hurtado O, Cárdenas A, Boscá L, Castillo J, Dávalos A, Vivancos J, Serena J, Lorenzo P, Lizasoain I, Moro MA (2006) Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through non-completely overlapping mechanisms. J Cereb Blood Flow Metab 26:218-229 (Pubitemid 43151578)
30. Reistad T, Mariussen E, Ring A, Fonnum F (2007) In Vitro Toxicity of Tetrabromobisphenol-A on Cerebellar Granule Cells: cell Death. Free Radical Formation, Calcium Influx and Extracellular Glutamate, Toxicological Sciences 96:268-278 (Pubitemid 46432023)
31. Ridder DA, Schwaninger M (2012) In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease. Exp Neurol 238:133-137
32. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A, Perdu E, Zalko D, Bourguet W, Balaguer P (2011a) Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A. Environ Health Perspect 119:1227-1232
33. Riu A, le Maire A, Grimaldi M, Audebert M, Hillenweck A, Bourguet W, Balaguer P, Zalko D (2011b) Characterization of novel ligands of ERα, Erß, and PPAR-γ: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol Sci 122:372-382
34. Schaefer KL, Takahashi H, Morales VM, Harris G, Barton S, Osawa E, Nakajima A, Saubermann LJ (2007) PPAR-γ Inhibitors Reduce Tubulin Protein Levels by a PPARgamma, PPARdelta and Proteasome-Independent Mechanism, Resulting in Cell Cycle Arrest, Apoptosis and Reduced Metastasis of Colorectal Carcinoma Cells. Int J Cancer 120:702-713 (Pubitemid 44969044)
35. Schauer UM, Völkel W, Dekant W (2006) Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration. Toxicol Sci 91:49-58
36. Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease. Neurotox Res 16:127-139
37. Seargent JM, Yates EA, Gill JH (2004) GW9662, a potent antagonist of PPAR-γ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPAR-γ agonist rosiglitazone, independently of PPARgamma activation. Br J Pharmacol 143:933-937 (Pubitemid 40065492)
38. Sellstrom U, Jansson B (1995) Analysis of tetrabromobisphenol a in a product and environmental-samples. Chemosphere 31:3085-3092
39. Shi H, Qian L, Guo S, Zhang X, Liu J, Cao Q (2010) Teratogenic effects of tetrabromobisphenol A on Xenopus tropicalis embryos. Comp Biochem Physiol C 152:62-68
40. Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D, Nagoya H, Greenberg JH (2005) A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36:353-359 (Pubitemid 40170822)
41. Sjödin A, Patterson DG Jr, Bergman A (2003) A review on human exposure to brominated flame retardants-particularly polybrominated diphenyl ethers. Environ Int 29:829-839 (Pubitemid 37337125)
42. Talsness CE, Andrade AJ, Kuriyama SN, Taylor JA, vom Saal FS (2009) Components of plastic: experimental studies in animals and relevance for human health. Philos Trans R Soc Lond B Biol Sci 364:2079-2096
43. Thomsen C, Lundanes E, Becher G (2002) Brominated flame retardants in archived serum samples from Norway: a study on temporal trends and the role of age. Environ Sci Technol 36:1414-1418 (Pubitemid 34279832)
44. Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, Vemuganti R (2007) Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 101:41-56 (Pubitemid 46426485)
45. Van der Ven LT, Van de Kuil T, Verhoef A, Verwer CM, Lilienthal H, Leonards PE, Schauer UM, Cantón RF, Litens S, De Jong FH, Visser TJ, Dekant W, Stern N, Håkansson H, Slob W, Van den Berg M, Vos JG, Piersma AH (2008) Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology 245:76-89
46. Viberg H, Eriksson P (2011) Differences in neonatal neurotoxicity of brominated flame retardants, PBDE 99 and TBBPA, in mice. Toxicology 289:59-65
47. Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, Terauchi Y, Tachibana M, Miyoshi H, Kamisaki Y, Mayumi T, Kadowaki T, Blumberg RS (2006) Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 281:12673-12681 (Pubitemid 43855357)
48. Yi KD, Covey DF, Simpkins JW (2009) Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem 108:732-740
49. Zeng Y, Xie K, Dong H, Zhang H, Wang F, Li Y, Xiong L (2012) Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma. Brain Res 1452:140-150
50. Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J (2006) Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity. Brain Res 1073-1074:460-469
51. Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, Grotta JC, Aronowski J (2007) Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol 61:352-362 (Pubitemid 46676735)
52. Zhao X, Strong R, Zhang J, Sun G, Tsien JZ, Cui Z, Grotta JC, Aronowski J (2009) Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J Neurosci 29:6186-6195
53. Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models. PLoS ONE 6:e15816